Cardiovascular risk and lupus disease

International Angiology

Volumn 30, Issue 1, 2011, Pages 18-24

  Boucelma, M ^a   Haddoum, F ^b   Chaudet, H ^c   Kaplanski, G ^c   Mazouni Brahimi, N ^d   Rezig Ladjouze, A ^d   Brouri, M ^d   Berrah, A ^a  

^a Bab El Oued Hospital   (Algeria)

^b Nephrology Nafisa Hamoud Hospital H Dey   (Algeria)

^c TIMONE HOSPITAL   (France)

^d Benyoucef Benkhedda   (Algeria)

Author keywords

Atherosclerosis; Cardiovascular diseases; Lupus erythematosus, systemic; Risk factors

Indexed keywords

CHOLESTEROL; HOMOCYSTEINE; PREDNISONE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANGINA PECTORIS; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; FEMALE; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYOCARDIAL PERFUSION IMAGING; PHYSICAL EXAMINATION; POPLITEAL ARTERY; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; TOMOSCINTIGRAPHY;

ADULT; AGE FACTORS; ALGERIA; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 79955368161     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Dubois E.L, Tuffanelli D.L. Clinical manifestations of systemic lupus erythematosus: Computer analysis of 520 cases. JAMA 1964;190:104-11.
2. th edition, 2, 2001:1455-79.
3. Jonsson H, Nived O, Surfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine 1989;68:141-50. (Pubitemid 19132411)
4. Cervera R, Khamashta M.A, Font J, Lavilla P, Sebastiani GD, Gil A, Lavilla P et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter- prospective study of 1000 patients. Medicine 1999;78:167-75. (Pubitemid 29231143)
5. Manzi S, Meilahn E.N, Rairie J.E, Conte CG, Medsger TA, Jansen-MCWilliams L et al. Age-specific rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study. AmJ Epidemiol 1997;45:408-15. (Pubitemid 27084212)
6. Shoenfield Y, Gerli R, Doria A, Matsuura I, Cerinic MM, Ronda N. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337-47. (Pubitemid 43739380)
7. Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nature Clin Pract Rheumatol 2006;2:1-8.
8. Rhew EY, Ramsey-Goldman R. Premature atherosclerosis disease in systemic lupus erythematosus: Role of inflammatory mechanisms. Autoimmun Rev 2006;5:101-5. (Pubitemid 43129536)
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of Systemic Lupus Erythematosus. Arthritis & Rheum 1997;40:1725.
10. Yee CS, Isenberg DA, Prabu A, Sokoll K, The LS, Rahman A. BILAG- 2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000. Arthritis Rheum 2008;6:630-40.
11. Carlson K. Lipoprotein fractionation. J Clin Pathol Suppl 1973;5:32-7.
12. Matzer L, Kiat H, Wang R, Van Train K, Germano G, Friedman J et al. Pharmacologic stress dual- isotope myocardial perfusion single-photon computed tomography. Am Heart J 1994;128:1067-76.
13. Heiss G, Sharret AR, Barnes R, Chambless LE, Sekko M, Alzola C. The ARIC investigators: Carotid atherosclerosis measured by B-Mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J of Epidemiology 1991;134:250-6.
14. Hirsch AT, Haskal BJ, Hertzer NR, Bakal CW, Creager YA, Halperin JL et al. ACC/AHA 2005 Guidelines for the patients with peripheral arterial disease. J Am Coll Cardiol 2006;47:1239-312.
15. Gensini GF, Comeglio M, Golella A. Classical risk factors and emerging damage elements in the risk profile for coronary artery. Eur Heart J 1998;19:A 53-61.
16. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
17. Shome GP, Sakauchi M, Yamane K, Takemora H, Kashiwagi M. Ischemic heart disease in systemic lupus: a retrospective study of 65 patients treated with prednisolone. Jpn J Med 1989;28:599-603. (Pubitemid 19273500)
18. Asanuma Y, Oeser A, Shintani A.K, Turner E, Olsen N, Fazio S, Linton MF et al. Premature coronary artery atherosclerosis in Systemic lupus erythematosus. N Engl Med 2003;349:2407-15. (Pubitemid 37542989)
19. Petri M, Perez G, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with SLE. Am J Med 1992;93:513-9.
20. Bulkley BH, William C, Roberts C. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975;58:243-64.
21. Haider YS, Roberts WC. Coronary arterial disease in systemic; lupus erythematosus: Quantification of degree of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 1981;70:775-81. (Pubitemid 11057007)
22. Salomon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid disease arthritis and SLE. Am J Med 2008;121:S3-8.
23. Kuller LH, Shemansky L, Psaty BM, Borhani NO, Gardin J, Haan MN et al. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation 1995;92:720-6.
24. Sella E.M.C, Sato I, Barbreri A. Myocardial perfusion scintigraphy and endothelial function in SLE. Arthritis & Rheum 2003;48:3168-175.
25. Bruce IN, Burns RJ, Gladman DD, Urowitz MB. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus I, Prevalence and distribution of abnormalities. J Rheumato 2000;27:2372-7.
26. Schillaci O, Lagana B, Danieli R, Gentile R, Tubiani L, Baratte L et al. Technetium-99m Sestamibi single photon emission tomography detects subclinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus. Eur Nucl Med 1999;26:713-7. (Pubitemid 29338659)
27. Sun SS, Shiau YC, Tsai SC, Lin CC, Kao A, Lee CC. The role of technetium-99 sestamibi myocardial perfusion single photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in SLE patients with non-specific complaints. Rheumatology 2001;40:1106-11.
28. Rahman P, Aguero S, Gladman DD, Hallett D, Urowitz MB. Vascular events in hypertensive patients with SLE. Lupus 2000;9:672-75.
29. Kitagawa Y, Rotoh F, Koto A, Kayaso M. Stroke in systemic lupus erythematosus. Stroke 1990;21:1533-9.
30. Svenungsson E, Jensen-Urstad K, Heimburger M, Silveria A, Hamsten A, De Faire U et al. Risk factor for cardiovascular disease in SLE. Circulation 2001;104:1887-93.
31. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R et al. Prevalence and correlates atherosclerosis in SLE. N Engl J Med 2003;349:2399-406. (Pubitemid 37542988)
32. Doria A, Shoenfield Y, Wu R, Gambari PF, Pueto M, Ghirardello A et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003;62:1071-7.
33. Selzer F, Sutton-Tyrell K, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH et al. Comparaison of risk factors for vascular disease in the carotid artery and aorta in women with SLE. Arthritis & Rheum 2004;50:151-9. (Pubitemid 38084299)
34. Manzi S, Selzer F, Sutton-Tyrrel K, Fitzgerald SG, Rairie JE, Tracy RP et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis & Rheum 1999;42:51-60. (Pubitemid 29042570)
35. Andreadis E, Tsourous G, Dimakakos.E, Marakomi HE, Fotia M, Diamantopoulos EG. Atheromatous plaque echogenicity at different sites of the arterial tree: Abstract. International Angiology 2004;23:S71.
36. Wolak H, Todosoui E, Szendro G, Bolotin A, Jonathan BS, Flusser D et al. Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study. J Rheumatology 2004;31:909-14. (Pubitemid 38585813)
37. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH et al. Prevention conference V, Beyond secondary prevention; Identifying the high risk patients for primary prevention by non-invasive test of atherosclerotic burden. Circulation 2000;101:16-22.
38. Lee AJ, Price JF, Russell MJ, Smith FB, Van Wijik MC, Fowkes FG. Improved prediction of fatal myocardial infarction using the ankle brachial index in addition to conventional risk factors: The Edinburgh artery study. Circulation 2004, 10:3075-80. (Pubitemid 39492001)
39. Doobay AV, Anand SS. Sensitivity and specificity of the ankle brachial index to predict future cardiovascular outcome: a systematic outcome. Arteriosclerosis Thromb Vasc Biol 2005;25:1463-9. (Pubitemid 40923369)
40. Theoridou A, Bento L, D'Cruz DP, Khamashta MA, Hughes GRV. Prevalence and associations of abnormal ankle brachial index in systemic. A pilot study. Ann Rheumatic Dis 2003;62:1199-203.
41. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1876-90. (Pubitemid 34219736)
42. Stanic AK, Stein CM, Morgan AC, Fazio S, Linton MR, Wakeland EK et al. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. PNAS 2006;103:7018-23.
43. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203.
44. McMahon M, Hahn BH. Atherosclerosis and systemic lupus erythematosus-mechanistic basis of the association. Current Opi Immunol 2007;19:633-9. (Pubitemid 350236815)
45. Mehra VC, Ramgdam VS, Bender JR. Cytokines and cardiovascular disease. J Leukoc Biol 2005;78:805-18.
46. Selzer F, Sutton-Tyrell K, Fitzerald SG, Tracy RP, Kuller LH, Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001;37:1075.
47. Toloza SM, Uribe AG, McGwin GJ, Alarcon GS, Fessier BJ, Bastian HM et al. Systemic lupus erythematosus in multiethnic US cohort (LUMINAXXIII). Baseline predictors of vascular events. Arthritis & Rheum 2004;50:3947-57.
48. Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-75. (Pubitemid 29424631)
49. Petri M, Roubenoff R, Dallal GE, Nadeau HR, Selhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996;348:1120-4. (Pubitemid 26358611)
50. Colombo BM, Cacciapaglia F, Puntoni M, Murdaca G, Rossi E, Rodriguez G et al. Traditional and non-traditional risk factors in accelerated atherosclerosis in SLE: Role of vascular endothelial growth factors (VEGATS Study). Autoimmun Rev 2009;8:309-15.
51. Voulilainen S, Morrow JD, Roberts LJ, Alfthan G, Alho H, Nyyssönen K et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 1999;19:1263-6.
52. Bruce IN, Urowitz MB, Gladman DD, Ibanez D, Steiner D. Risk factor for coronary heart disease in women with SLE. Arthritis & Rheum 2003;48:3159-67.
53. El Magadmi M, Bodill H, Durrington PN, Walker M, Berstein RM, Bruce IN. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004;4:399-404. (Pubitemid 38993848)
54. Wajed J, Ahmed Y, Durrington PN, Bruce IN. Prevention of cardiovascular disease on systemic lupus erythematosus proposed guidelines of risk factor management. Rheumatology 2004;43:7-12. (Pubitemid 38088360)